December 2007

We asked our participants for their insights and opinions on the impact of social and emotional impairments associated with ADHD, considerations for the patient, consequences for the payer, and cost implications across the life span. Strattera® (atomoxetine HCl) is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children age 6 and older, adolescents, and adults.

ADHD is a common presentation in all clinical settings. However, data shows that ADHD is underrecognized in adults.1 Why is this? Remember the old adage, "Out of sight, out of mind?" If ADHD is not thought of as a possibility in adult patients, is it more likely to be missed?

This article provides answers to several common questions associated with the use of Strattera® (atomoxetine HCl) to treat patients with ADHD. Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children age 6 and older, adolescents, and adults.